Does the progress in diagnosing Leśniowski-Crohn\'s disease correlate with the therapeutic procedures?
Journal Title: Gastroenterology Review - Year 2006, Vol 1, Issue 2
Abstract
The progress in molecular analyses of genetic predisposition to Leśniowski-Crohn’s disease does not correlate with therapeutical progress. There is a constant comparison of “step-up” and “top-down” treatment, more and more often there is a discussion about effectiveness of steroids and benefits of using AZA and 6MP. The medical study proves more indications for biological treatment. There is also a progress in farmacogenetics as a method for prognosing the farmacological effectiveness. Unfortunately there is no really effective method of treatment in Leśniowski-Crohn’s disease. That is the reason why unconventional methods of treatment are taken into consideration.
Authors and Affiliations
Agnieszka Dobrowolska-Zachwieja
Traditions of European Pancreatic Club and the creation of Polish Pancreatic Club
The European Pancreatic Club (EPC) was created during the initial meeting in London, 9-10, December 1965. The idea was to foster communication between basic scientists and clinicians with special interest in the pancreas...
Sprawozdanie z warsztatów dotyczących biologicznej terapii nieswoistych chorób zapalnych jelit
Wywiad z prof. Beatą Kos-Kudłą
Metabolic complications of Leśniowski-Crohn\'s desease
Metabolic complications presented in Leśniowski-Crohn disease are consequences of multiple factors involved in pathogenesis of this entity, which leads to malabsorption, malnutrition as well as vitamin and mineral defici...
Autoimmune pancreatitis - case report, diagnostic, treatment
Autoimmune pacreatitis is a rare disorder with presumed autoimmune etiology that is associated with characteristic clinical, histological, and morphologic findings. We report a case a 32-years old female with AIP and dis...